Position in NVO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$21,525,347
+$21,308,486 QoQ
Shares Held
449,006
+7509.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#92
of 1,348 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. NVO ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
|
50,310 | $18,218,257 |
All Filings in NVO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,525,347 | 449,006 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $216,861 | 5,901 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $669,835 | 13,165 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,164,291 | 20,982 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $228,939 | 3,317 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $453,789 | 6,535 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $681,622 | 7,924 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $429,722 | 3,609 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $519,144 | 3,637 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $487,277 | 3,795 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $411,523 | 3,978 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $208,161 | 2,289 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $172,834 | 1,068 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $168,688 | 1,060 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $130,873 | 967 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $98,135 | 985 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $99,952 | 897 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $60,078 | 541 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,816 | 43 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $768 | 8 | Shares | Sole | 2021-11-05 | |
| 2020-12-31 | $8,102 | 116 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $8,053 | 116 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,530 | 115 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $6,862 | 114 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||